glutathione bromopyruvic acid conjugate 3-Bromopyruvic (Bromopyruvic acid) | Hexokinase II Inhibitor 3-Bromopyruvic Acid
3 Bromopyruvic Acid 3 Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy dependent ferroptosis Cancer Gene Therapy Conjugation With Glutathione and Mercapturic Acid Formation Biotransformation of Drugs A, 3 bromopyruvate (3BP) targets critical steps in cancer cell biology. Download Scientific Diagram Frontiers Glutathione S conjugates as prodrugs to target drug resistant tumors The promising anticancer drug 3 bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence based view ScienceDirect
Pay in 4 interest-free payments of $7.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





